Lv2
180 积分 2025-12-30 加入
KRAS alterations combined with TP53 mutations as novel synthetic lethal genomic lesions for PKMYT1 inhibition
4个月前
已关闭
Combinatorial use of VHL and KEAP1 PROTACs reveals unexpected synergy and hook effect relief
4个月前
已完结
Lessons learned in linking PROTACs from discovery to the clinic
4个月前
已完结
Target and tissue selectivity of PROTAC degraders
4个月前
已完结